Celltrion’s Monoclonal Antibody Treatment Regdanvimab, Approved By The European Commission For The Treatment Of COVID-19
· The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following positive opinion by the European Medicines Agency’s (EMA) Committee…


